2929.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 08:15):

Stats
Dagens volum	98 500.00
Gjennomsnittsvolum	317 976
Markedsverdi	24.00B
EPS	¥16.76 ( 2024-03-11 )
Neste inntjeningsdato	( ¥0 ) 2024-06-02
Last Dividend	¥12.00 ( 2023-07-28 )
Next Dividend	¥0 ( N/A )
P/E	5.18
ATR14	¥0.321 (0.04%)

Volum Korrelasjon

Lang: 0.20 (neutral)

Kort: 0.67 (moderate)

Signal:(55.405) Neutral

Pharma Foods Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pharma Foods Korrelasjon - Valuta/Råvare

-0.25
( neutral )

-0.13
( neutral )

-0.09
( neutral )

-0.01
( neutral )

0.07
( neutral )

Pharma Foods Økonomi

Annual	2023
Omsetning:	¥68.57B
Bruttogevinst:	¥55.28B (80.61 %)
EPS:	¥106.70

FY	2023
Omsetning:	¥68.57B
Bruttogevinst:	¥55.28B (80.61 %)
EPS:	¥106.70

FY	2022
Omsetning:	¥60.19B
Bruttogevinst:	¥48.11B (79.93 %)
EPS:	¥-12.89

FY	2021
Omsetning:	¥46.75B
Bruttogevinst:	¥39.73B (84.97 %)
EPS:	¥132.27

Financial Reports:

No articles found.

Pharma Foods Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥10.00 (N/A)	¥0 (N/A)	¥10.00 (N/A)	¥0 (N/A)	¥12.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Pharma Foods Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.02 - good (80.25%) | Divividend Growth Potential Score: 4.25 - Stable (15.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥3.50	2020-01-30
Last Dividend	¥12.00	2023-07-28
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	¥60.50	--
Avg. Dividend % Per Year	0.00%	--
Score	2.93	--
Div. Sustainability Score	8.02
Div.Growth Potential Score	4.25
Div. Directional Score	6.14	--

Next Divdend (Est)
(2024-07-01)

¥0 Estimate 7.69 %

Dividend Stability

0.31 Poor

Dividend Score

2.93

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8365.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7745.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6927.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6289.T	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
5011.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
4212.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3420.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2502.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
9436.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8089.T	Ex Dividend Junior	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0732	1.500	8.54	10.00	[0 - 0.5]
returnOnAssetsTTM	0.129	1.200	5.71	6.85	[0 - 0.3]
returnOnEquityTTM	0.528	1.500	5.24	7.86	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.072	0.800	9.64	7.71	[1 - 3]
quickRatioTTM	0.813	0.800	9.92	7.94	[0.8 - 2.5]
cashRatioTTM	0.659	1.500	7.45	10.00	[0.2 - 2]
debtRatioTTM	0.538	-1.500	1.038	-1.557	[0 - 0.6]
interestCoverageTTM	115.92	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	30.09	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	30.09	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	2.16	-1.500	1.347	-2.02	[0 - 2.5]
grossProfitMarginTTM	0.798	1.000	0.0286	0.0286	[0.2 - 0.8]
operatingProfitMarginTTM	0.0926	1.000	-0.148	-0.148	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0435	1.000	-0.869	-0.869	[0.2 - 2]
assetTurnoverTTM	1.758	0.800	1.613	1.291	[0.5 - 2]
Total Score				8.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.15	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.528	2.50	6.94	7.86	[0.1 - 1.5]
freeCashFlowPerShareTTM	30.09	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.58	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	30.09	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00555	1.500	-3.30	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0133	1.000	-2.17	0	[0.1 - 0.5]
Total Score				4.25

Pharma Foods

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.